In Belgium, high-risk contacts of an infected person were offered PCR-testing irrespective of their vaccination status. We estimated vaccine effectiveness (VE) against infection and onwards transmission, controlling for previous infections, household-exposure and temporal trends. We included 301,741 tests from 25 January to 24 June 2021. Full-schedule vaccination was associated with significant protection against infection. In addition, mRNA-vaccines reduced onward transmission: VE-estimates increased to >90% when index and contact were fully vaccinated. The small number of viral-vector vaccines included limited interpretability.</p
While contact tracing and case isolation are considered as the first choice of interventions against...
Background We provide national estimates of the real-world Vaccine effectiveness (VE) based on natio...
Background: The current Belgian experience with rotavirus vaccination provides a unique perspective ...
In Belgium, high-risk contacts of an infected person were offered PCR-testing irrespective of their ...
BACKGROUND: During the first half of 2021, we observed high vaccine effectiveness (VE) against SARS-...
BACKGROUND: Contact tracing is one of the main public health tools in the control of coronavirus dis...
This paper uses large cross-country data for 110 countries to examine the effectiveness of COVID vac...
BackgroundTo inform public health policy, it is critical to monitor coronavirus disease 2019 vaccine...
The objective of this study was to investigate the incidence and risk factors associated with COVID-...
The computer simulation presented in this study aimed to investigate the effect of contact tracing o...
The objective of this study was to investigate the incidence and risk factors associated with COVID-...
By employing a common protocol and data from electronic health registries in Denmark, Navarre (Spain...
International audienceBACKGROUND: Measuring vaccine effectiveness (VE) using real-life data is criti...
BACKGROUND: With the spread of coronavirus disease 2019 (COVID-19), an existing national laboratory-...
The national vaccination campaign against SARS-CoV-2 started in January 2021 in Belgium. In the pres...
While contact tracing and case isolation are considered as the first choice of interventions against...
Background We provide national estimates of the real-world Vaccine effectiveness (VE) based on natio...
Background: The current Belgian experience with rotavirus vaccination provides a unique perspective ...
In Belgium, high-risk contacts of an infected person were offered PCR-testing irrespective of their ...
BACKGROUND: During the first half of 2021, we observed high vaccine effectiveness (VE) against SARS-...
BACKGROUND: Contact tracing is one of the main public health tools in the control of coronavirus dis...
This paper uses large cross-country data for 110 countries to examine the effectiveness of COVID vac...
BackgroundTo inform public health policy, it is critical to monitor coronavirus disease 2019 vaccine...
The objective of this study was to investigate the incidence and risk factors associated with COVID-...
The computer simulation presented in this study aimed to investigate the effect of contact tracing o...
The objective of this study was to investigate the incidence and risk factors associated with COVID-...
By employing a common protocol and data from electronic health registries in Denmark, Navarre (Spain...
International audienceBACKGROUND: Measuring vaccine effectiveness (VE) using real-life data is criti...
BACKGROUND: With the spread of coronavirus disease 2019 (COVID-19), an existing national laboratory-...
The national vaccination campaign against SARS-CoV-2 started in January 2021 in Belgium. In the pres...
While contact tracing and case isolation are considered as the first choice of interventions against...
Background We provide national estimates of the real-world Vaccine effectiveness (VE) based on natio...
Background: The current Belgian experience with rotavirus vaccination provides a unique perspective ...